{
    "nctId": "NCT04344496",
    "briefTitle": "East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction",
    "officialTitle": "The Cancer Genome Atlas and Recurrence Risk Prediction of East Asian Breast Cancer: a Multicenter Collaborative Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 2000,
    "primaryOutcomeMeasure": "Prevalence of unique genetic alterations",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 1. Aged more than 20-year-old at the time of informed consent.\n* 2. An unconfirmed breast tumor, or have histologically confirmed invasive breast cancer.\n* 3. Have radiological or objective evidence of breast tumor size \u22651 cm.\n* 4. Be able to comply with study procedures to collect the clinical medical information, blood sample, fresh tumor tissue, and 12 sections of paraffin embedded tumor tissue.\n* 5. Be able to sign an informed consent.\n\nExclusion Criteria:\n\n* 1. Have histologically confirmed ductal carcinoma in situ (DCIS).\n* 2. Stage I, II or III breast cancer patients who have received neoadjuvant treatments, including chemotherapy, hormonal therapy, or targeted therapy.\n* 3. Stage IV or metastatic breast cancer patients who have received chemotherapy.",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}